ABBV vs ECG · P/E 81, rev $61.16B vs P/E 35, rev $2.85B
AbbVie Inc (ABBV) versus Everus Construction Group Inc (ECG) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Everus Construction Group Inc (ECG) is a engineering & construction company listed on NYSE.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported ECG revenue for 2024-12-31 was $2.85B. Net income was $143.4M. Revenue was down 0.2% from 2023-12-31 to 2024-12-31. ECG currently screens at market cap $7.87B and trailing P/E 35.3.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. ECG currently screens at market cap $7.87B and trailing P/E 35.3.
Not investment advice. Open the ABBV and ECG stock pages for the full models.
Not investment advice.